• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例半乳糖血症(由于半乳糖变位酶缺乏)患者部分饮食自由化后的临床和生化演变。

Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency.

机构信息

Diagnosis and Treatment Unit of Congenital Metabolic Diseases (UDyTEMC), Clinical University Hospital of Santiago de Compostela. National Reference Center for Metabolic Diseases (C.S.U.R.), Santiago de Compostela, Spain.

IDIS-Health Research Institute of Santiago de Compostela, Santiago de Compostela, 15704, Spain.

出版信息

BMC Pediatr. 2024 Sep 30;24(1):620. doi: 10.1186/s12887-024-05074-6.

DOI:10.1186/s12887-024-05074-6
PMID:39350089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441068/
Abstract

BACKGROUND

The recommended diet attitude in the recently described galactose mutarotase (GALM) deficiency is not yet established. We describe two 9-years twins who remain asymptomatic despite prolonged partial dietary liberalization from 18 months of age, after two periods of galactose-free diet. It represents the second report in Europe of GALM deficiency.

CASE PRESENTATION

Two male monochorionic diamniotic twins were detected through newborn screening by galactosuria and increased total blood galactose. They started galactose dietary restriction with biochemical normalization. After exclusion of the three previously described types of galactosemia, a progressively galactose reintroduction was initiated. The clinical follow-up developed include neurological assessment and intelligence quotient, annual ophthalmological evaluation and biannual abdominal ultrasound; whereas the biochemical assessment comprises quarterly determinations of galactose 1-phosphate and galactosuria and annual determination of liver and renal function, 25-OH-vitamin D and calcium levels. Sanger sequencing of GALM gene was complemented by the study of gene dose using SNPs array and a protein modeling to study the conformational changes induced in GALM protein. In both siblings a novel and complete deletion of exon 4 in GALM gene was detected. Both remained asymptomatic, with normal growth and intellectual development, despite dietary liberalization. Evolutionarily, the biochemical profile in blood remained normal with intermittent galactosuria.

CONCLUSIONS

The absence of clinical involvement after 7 years of dietary liberalization is interesting to expand the knowledge about the recommended dietary management in this pathology.

摘要

背景

最近描述的半乳糖差向异构酶(GALM)缺乏症的推荐饮食态度尚未确定。我们描述了两个 9 岁的双胞胎,尽管在 18 个月大后进行了两次无 galactose 饮食,仍持续部分饮食自由化,但仍无症状。这是欧洲第二例 GALM 缺乏症报告。

病例介绍

两名男性同卵双胎双胞胎通过尿半乳糖和总血半乳糖升高在新生儿筛查中被发现。他们开始进行 galactose 饮食限制,生化指标正常。排除了之前描述的三种半乳糖血症后,开始逐步重新引入 galactose。临床随访包括神经评估和智商、每年进行眼科评估和每两年进行一次腹部超声检查;生化评估包括每季度测定半乳糖 1-磷酸和尿半乳糖,以及每年测定肝肾功能、25-OH-维生素 D 和钙水平。GALM 基因的 Sanger 测序通过 SNP 阵列研究基因剂量和 GALM 蛋白构象变化的蛋白建模进行补充。在两个兄弟姐妹中,均检测到 GALM 基因外显子 4 的完整缺失。尽管进行了饮食自由化,但他们仍然无症状,生长和智力发育正常。从进化的角度来看,血液中的生化特征保持正常,间歇性出现半乳糖尿。

结论

在饮食自由化 7 年后没有出现临床症状,这有助于扩展我们对该病理学中推荐饮食管理的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c17/11441068/bd42b015a15d/12887_2024_5074_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c17/11441068/bd42b015a15d/12887_2024_5074_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c17/11441068/bd42b015a15d/12887_2024_5074_Fig1_HTML.jpg

相似文献

1
Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency.两例半乳糖血症(由于半乳糖变位酶缺乏)患者部分饮食自由化后的临床和生化演变。
BMC Pediatr. 2024 Sep 30;24(1):620. doi: 10.1186/s12887-024-05074-6.
2
Classic Galactosemia and Clinical Variant Galactosemia经典型半乳糖血症和临床变异型半乳糖血症
3
Duarte Variant Galactosemia杜阿尔特变异型半乳糖血症
4
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
5
β-Galactosidase therapy can mitigate blood galactose elevation after an oral lactose load in galactose mutarotase deficiency.β-半乳糖苷酶治疗可减轻半乳糖差向异构酶缺乏症患者口服乳糖负荷后血液半乳糖升高。
J Inherit Metab Dis. 2022 Mar;45(2):334-339. doi: 10.1002/jimd.12444. Epub 2021 Oct 13.
6
-Related Tetrahydrobiopterin Deficiency (PTPSD)- 相关四氢生物蝶呤缺乏症(PTPSD)
7
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Biallelic GALM pathogenic variants cause a novel type of galactosemia.双等位基因 GALM 致病性变异导致一种新型半乳糖血症。
Genet Med. 2019 Jun;21(6):1286-1294. doi: 10.1038/s41436-018-0340-x. Epub 2018 Oct 19.
10
Citrullinemia Type II型瓜氨酸血症

引用本文的文献

1
Rethinking Newborn Screening: A Case of GALM Deficiency.重新思考新生儿筛查:一例半乳糖脑苷脂酶缺乏症病例
Int J Neonatal Screen. 2025 Apr 11;11(2):25. doi: 10.3390/ijns11020025.

本文引用的文献

1
Phenotypic and genetic spectra of galactose mutarotase deficiency: A nationwide survey conducted in Japan.半乳糖差向异构酶缺乏症的表型和基因型谱:日本全国性调查。
Genet Med. 2024 Aug;26(8):101165. doi: 10.1016/j.gim.2024.101165. Epub 2024 May 16.
2
Two siblings with galactose mutarotase deficiency: Clinical differences.两名患有半乳糖变旋酶缺乏症的兄弟姐妹:临床差异。
JIMD Rep. 2021 Nov 29;63(1):25-28. doi: 10.1002/jmd2.12263. eCollection 2022 Jan.
3
The Discovery of GALM Deficiency (Type IV Galactosemia) and Newborn Screening System for Galactosemia in Japan.
半乳糖激酶缺乏症(IV型半乳糖血症)的发现及日本半乳糖血症新生儿筛查系统
Int J Neonatal Screen. 2021 Oct 25;7(4):68. doi: 10.3390/ijns7040068.
4
β-Galactosidase therapy can mitigate blood galactose elevation after an oral lactose load in galactose mutarotase deficiency.β-半乳糖苷酶治疗可减轻半乳糖差向异构酶缺乏症患者口服乳糖负荷后血液半乳糖升高。
J Inherit Metab Dis. 2022 Mar;45(2):334-339. doi: 10.1002/jimd.12444. Epub 2021 Oct 13.
5
The structural and molecular biology of type IV galactosemia.IV 型半乳糖血症的结构和分子生物学。
Biochimie. 2021 Apr;183:13-17. doi: 10.1016/j.biochi.2020.11.001. Epub 2020 Nov 9.
6
Correction: Biallelic GALM pathogenic variants cause a novel type of galactosemia.更正:双等位基因GALM致病变异导致一种新型半乳糖血症。
Genet Med. 2020 Jul;22(7):1281. doi: 10.1038/s41436-020-0836-z.
7
The prevalence of GALM mutations that cause galactosemia: A database of functionally evaluated variants.GALM 突变导致半乳糖血症的患病率:一个经过功能评估的变异体数据库。
Mol Genet Metab. 2019 Apr;126(4):362-367. doi: 10.1016/j.ymgme.2019.01.018. Epub 2019 Mar 18.
8
Type IV galactosemia.IV型半乳糖血症
Genet Med. 2019 Jun;21(6):1283-1285. doi: 10.1038/s41436-018-0359-z. Epub 2018 Nov 21.
9
Biallelic GALM pathogenic variants cause a novel type of galactosemia.双等位基因 GALM 致病性变异导致一种新型半乳糖血症。
Genet Med. 2019 Jun;21(6):1286-1294. doi: 10.1038/s41436-018-0340-x. Epub 2018 Oct 19.
10
Molecular structure of human galactose mutarotase.
J Biol Chem. 2004 May 28;279(22):23431-7. doi: 10.1074/jbc.M402347200. Epub 2004 Mar 16.